Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study. 1982

S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein

The effects of verapamil were assessed in 26 patients with stable exertional angina pectoris in a double-blind, placebo-controlled, randomized crossover protocol using serial treadmill tests. Verapamil, 480 mg/day, reduced anginal frequency from 5.6 +/- 7.3 to 2.2 +/- 3.9 attacks per week (p less than 0.001) and nitroglycerin consumption from 3.4 +/- 4.9 to 1.2 +/- 2.5 tablets per week (p less than 0.05) compared with placebo. Treadmill time increased from 6.4 +/- 2.1 minutes during the placebo phase to 7.5 +/- 1.8 minutes during the verapamil phase (p less than 0.001). Verapamil's beneficial effect appeared to be related, in part, to a 10% reduction of the rate-pressure product at rest (p less than 0.05) and a 12% reduction during submaximal exercise (p less than 0.001). Verapamil also caused less marked ST-segment depressions at peak exercise (p less than 0.05) at a similar rate-pressure product, suggesting a favorable redistribution of coronary blood flow to the ischemic zone. Side effects from verapamil were minimal, consisting mainly of constipation (six patients). Verapamil appears to be a safe and effective drug for treating angina of effort.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
November 1990, European heart journal,
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
April 1988, Annales de cardiologie et d'angeiologie,
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
December 1980, Circulation,
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
March 1995, American heart journal,
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
January 1988, European heart journal,
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
March 1983, The American journal of cardiology,
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
May 1993, Giornale italiano di cardiologia,
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
November 2016, Future cardiology,
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
April 1988, Cardiologia (Rome, Italy),
S J Brodsky, and S S Cutler, and D A Weiner, and C H McCabe, and T J Ryan, and M D Klein
September 1981, The American journal of medicine,
Copied contents to your clipboard!